Holen Sie sich die Stockscreener-App
3.20
0.63%
0.02
Handel nachbörslich:
3.14
-0.06
-1.88%
Schlusskurs vom Vortag:
$3.18
Offen:
$3.08
24-Stunden-Volumen:
29,228
Relative Volume:
0.01
Marktkapitalisierung:
$13.86M
Einnahmen:
$2.07M
Nettoeinkommen (Verlust:
$-3.53M
KGV:
-2.7204
EPS:
-1.1763
Netto-Cashflow:
$-3.31M
1W Leistung:
+6.67%
1M Leistung:
+8.84%
6M Leistung:
+110.53%
1J Leistung:
-2.14%
1-Tages-Spanne:
$3.01
$3.20
1-Wochen-Bereich:
$2.98
$3.35
52-Wochen-Spanne:
$1.0266
$8.48
Cyclerion Therapeutics Inc Stock (CYCN) Company Profile
Firmenname
Cyclerion Therapeutics Inc
Sektor
Branche
Telefon
617-621-7722
Adresse
301 BINNEY STREET, CAMBRIDGE, MA
Compare CYCN vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CYCN
Cyclerion Therapeutics Inc
|
3.20 | 13.77M | 2.07M | -3.53M | -3.31M | -1.1763 |
VRTX
Vertex Pharmaceuticals Inc
|
435.93 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.62 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.43 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.50 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Cyclerion Therapeutics Inc Stock (CYCN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-10-20 | Eingeleitet | Truist | Buy |
| 2021-09-24 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-06-03 | Eingeleitet | Credit Suisse | Neutral |
Cyclerion Therapeutics Inc Aktie (CYCN) Neueste Nachrichten
Cyclerion Shares to Watch With Deal in Focus as Markets Reopen - Bez Kabli
Cyclerion Therapeutics stock soars 350% on Korsana merger, $380 million financing - MSN
Cyclerion Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Korsana deal and cash crunch reshape Cyclerion (NASDAQ: CYCN) outlook - Stock Titan
TradingKey - TradingKey
CYCN News | CYCLERION THERAPEUTICS INC (NASDAQ:CYCN) - ChartMill
Why Cyclerion (CYCN) deserves a deeper look right now (-2.78%) 2026-05-07Insider Info - newser.com
FMR LLC holds 15.0% of Cyclerion Therapeutics (NASDAQ: CYCN) in Schedule 13G - Stock Titan
Are OGN, TBRG, CYCN Obtaining Fair Deals for their Shareholders? - Sahm
CYCN | Cyclerion Therapeutics, Inc. Common Insider Trading - Quiver Quantitative
Cyclerion Therapeutics 2024 10-K/A Amendment: Executive Compensation, Governance, and Equity Awards Overview - Minichart
Cyclerion Therapeutics (NASDAQ: CYCN) updates board, compensation and PIPE details - Stock Titan
CYCN stock is soaring 150% pre-market today — what is fueling the rally? - MSN
CYCN SEC FilingsCyclerion Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Cyclerion Merges with Korsana to Develop Alzheimer Antibody Therapy - HarianBasis.co
Cyclerion Therapeutics (CYCN) Merges With Korsana Biosciences to Advance Alzheimer’s Pipeline - Insider Monkey
5 Unstoppable Stocks That Could Double Your Money - Insider Monkey
Is Cyclerion (CYCN) stock outperforming similar companies (Drifts Higher) 2026-04-18Open Stock Signal Network - Xã Thanh Hà
EDGAR Filing Documents for 0001193125-26-162177 - SEC.gov
Published on: 2026-04-13 23:21:17 - baoquankhu1.vn
Guidance Update: Is Cyclerion Therapeutics Incs growth already priced inEarnings Recap Summary & Fast Entry Momentum Alerts - baoquankhu1.vn
Finance Watch: Replimune Cutting Jobs As FDA Rejects RP1 A Second Time - Citeline News & Insights
Are UNF, NSA, CYCN, ULYX Obtaining Fair Deals for their Shareholders? - Finviz
Are UNF, NSA, CYCN, ULYX Obtaining Fair Deals for their Sharehol - GuruFocus
Fed Watch: Is Cyclerion Therapeutics Incs growth already priced inQuarterly Earnings Summary & AI Optimized Trade Strategies - baoquankhu1.vn
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Cyclerion Therapeutics, Inc. (Nasdaq – CYCN), National Storage Affiliates (NYSENSA), Urgent.ly, Inc. (OTC MarketsULYX), UniFirst Corporation (NYSEU - ChartMill
12 Health Care Stocks Moving In Tuesday's After-Market Session - Sahm
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Rate Hike: Is Cyclerion Therapeutics Incs growth already priced in2026 Historical Comparison & Expert Approved Momentum Ideas - baoquankhu1.vn
Halper Sadeh LLC is Investigating Whether SLNO, FORA, MKC, CYCN are Obtaining Fair Deals for their Shareholders - GlobeNewswire Inc.
Halper Sadeh LLC is Investigating Whether SLNO, FORA, MKC, CYCN are Obtaining Fair Deals for their Shareholders - GlobeNewswire
Alzheimer’s company Korsana heads to NASDAQ via merger: Deals Report - BioCentury
Monday's session: gap up and gap down stocks - ChartMill
Penny stock CYCN surged more than 300% yesterday. Why, and should you chase the rally here? - MSN
CYCN PE Ratio & Valuation, Is CYCN Overvalued - Intellectia AI
CYCN Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
If You Invested $1,000 in Cyclerion Therapeutics Inc (CYCN) - Stock Titan
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Sahm
Globalstar, Exxon Mobil, Cyclerion Therapeutics, Eli Lilly And Intel: Why These 5 Stocks Are On Investors' Radars Today - Sahm
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Cyclerion Therapeutics, Inc. (NASDAQ: CYCN) - Sahm
Korsana Biosciences and Cyclerion Therapeutics Announce All-Stock Merger and $380 Million Financing - Global Legal Chronicle
Monteverde & Associates Investigates Cyclerion Therapeutics Merger - National Today
CYCN Plunges 17% After Merger Announcement: What’s Next for Cyclerion and Korsana? - Bitget
Cyclerion and Korsana Tie the Knot with a New Merger Strategy - StocksToTrade
Cyclerion Therapeutics Merger Sparks Investor Uncertainty - timothysykes.com
Penny Stock CYCN Surged More Than 300% Yesterday. Why, And Should You Chase the Rally Here? - Barchart.com
Korsana boosts Alzheimer’s work with reverse merger, $380M financing - BioWorld News
CYCN Stock Alert: Halper Sadeh LLC is Investigating Whether Cycle - The National Law Review
Cyclerion Therapeutics and Korsana Biosciences Announce $380M Merger to Advance Alzheimer’s Treatment KRSA-028 - Minichart
Finanzdaten der Cyclerion Therapeutics Inc-Aktie (CYCN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.98%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):